Integrated Microfluidic Device for Serum Biomarker Quantitation Using Either Standard Addition or a Calibration Curve

Department of Chemistry and Biochemistry, Brigham Young University, Provo, Utah 84602, USA.
Analytical Chemistry (Impact Factor: 5.83). 10/2009; 81(19):8230-5. DOI: 10.1021/ac901566s
Source: PubMed

ABSTRACT Detection and accurate quantitation of biomarkers such as alpha-fetoprotein (AFP) can be a key aspect of early stage cancer diagnosis. Microfluidic devices provide attractive analysis capabilities, including low sample and reagent consumption, as well as short assay times. However, to date microfluidic analyzers have relied almost exclusively on calibration curves for sample quantitation, which can be problematic for complex mixtures such as human serum. We have fabricated integrated polymer microfluidic systems that can quantitatively determine fluorescently labeled AFP in human serum using either the method of standard addition or a calibration curve. Our microdevices couple an immunoaffinity purification step with rapid microchip electrophoresis separation in a laser-induced fluorescence detection system, all under automated voltage control in a miniaturized polymer microchip. In conjunction with laser-induced fluorescence detection, these systems can quantify AFP at approximately 1 ng/mL levels in approximately 10 microL of human serum in a few tens of minutes. Our polymer microdevices have been applied in determining AFP in spiked serum samples. These integrated microsystems offer excellent potential for rapid, simple, and accurate biomarker quantitation in a point-of-care setting.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Detection and accurate quantification of biomarkers are key aspects of early stage cancer diagnosis. An electrochemical sandwich immunosensor for sensitive detection of cancer biomarkers was developed by using graphene as the sensing platform and diazonium chemistry as the immobilization method. The glassy carbon electrode was first modified with graphene and the resulting graphene modified electrode offered an excellent platform for high performance biosensing applications. The immunosensor was fabricated by covalently coupling the capture antibody onto the surface of the graphene modified electrode, which was first electrochemically grafted with an aminophenyl group by reduction of the in situ generated aminophenyl diazonium cation generated from p-phenylenediamine, using glutaraldehyde as the cross-linker. A sandwich immunoassay for alpha-fetoprotein (AFP), a biomarker of liver cancer that was used as a model, was developed using the horseradish peroxidase-conjugated anti-AFP antibody as the electrochemical probe. The electrochemical immunosensor exhibited high sensitivity and specificity for the detection of AFP. A linear relationship between electrochemical signals and the concentrations of AFP was obtained in the range from 0.1 ng mL−1 to 2 ng mL−1. The detection limit of AFP was 0.03 ng mL−1 (S/N = 3). This work demonstrates that the employment of graphene as a novel sensing platform and diazonium chemistry as an immobilization method is a promising approach to a stable and sensitive determination of biomolecules and will be promising in the point-of-care diagnostics application of clinical screening of cancer biomarkers.
    Analytical methods 09/2013; 5(19). DOI:10.1039/C3AY40739J · 1.94 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In this study, we established a sensitive label-free immunosensor by palladium-reduced graphene oxide (Pd-rGO), which was prepared by one-pot synthesis under the reduction of extra-injected CO gas. The Pd-rGO nanocomposite structure has been confirmed by TEM, SEM, X-ray diffraction, and UV-vis spectroscopy. The Pd-rGO nanocomposite exhibited excellent stability in aqueous dispersion. The Pd-rGO-based label-free electrochemical immunosensor was used for detection of the hepatocellular carcinoma (HCC) biomarker alpha fetoprotein (AFP). The immunosensor determination was based on the fact that due to the formation of antigen-antibody immunocomplex, the decreased response amperometric currents of H2O2 were directly proportional to the concentrations of AFP. The limit of detection of this immunosensor for AFP detection is 5pg/mL, and is linear from 0.01 to 12ng/mL. The proposed immunosensor has been used to determine AFP in clinical serum samples with satisfactory results. This suggests the sensor may have great potential utility in the clinic.
    Biosensors & Bioelectronics 05/2014; 61C:245-250. DOI:10.1016/j.bios.2014.05.021 · 6.45 Impact Factor
  • Chemical Reviews 02/2013; 113(4). DOI:10.1021/cr300337x · 45.66 Impact Factor

Full-text (2 Sources)

Available from
Jun 1, 2014